Chris H. Takimoto, Chief Medical Officer at IGM Biosciences, Inc. (IGMS), sold 938 shares at $17.10 ($16K) on 2022-05-24, disclosed to the SEC on 2022-05-26.
Open-market sale of $16k IGMS by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IGMS | SELL | 2024-03-15 | $54K | — | Filing → |
| IGMS | SELL | 2023-12-01 | $7K | — | Filing → |
| IGMS | SELL | 2023-05-25 | $15K | — | Filing → |